Neurodon is a development-stage pharmaceutical company that is developing disease-modifying molecules targeting neurodegeneration, diabetes, and other life-threatening conditions by deploying a proprietary ER stress-based technology platform—halting diseases and improving lives with innovative small molecule therapies.

Biotechnology

Neurodon

Neurodon's headquarters in Crown Point, IN, United States

Russell Dahl

Brunde Broady

Seth L. Robia

Ilya Bezprozvanny

D. James Surmeier

John Amatruda

Neurodon's Leadership Team includes Colleen Mauger and 1 others.

About

People (1)

Russell Dahl

Jobs